In November 2017, the American College of Cardiology (ACC) and the American Heart Association (AHA) released a clinical practice guideline for the prevention, detection, evaluation, and treatment of high blood pressure (BP) in adults. This article summarizes the major recommendations.

In 2014, the ACC and the AHA appointed a multidisciplinary committee to update previous reports of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The committee reviewed literature and commissioned systematic reviews and meta-analyses on out-of-office BP monitoring, the optimal target for BP lowering, the comparative benefits and harms of different classes of antihypertensive agents, and the comparative benefits and harms of initiating therapy with a single antihypertensive agent or a combination of 2 agents.

This article summarizes key recommendations in the following areas: BP classification, BP measurement, screening for secondary hypertension, nonpharmacologic therapy, BP thresholds and cardiac risk estimation to guide drug treatment, treatment goals (general and for patients with diabetes mellitus, chronic kidney disease, and advanced age), choice of initial drug therapy, resistant hypertension, and strategies to improve hypertension control.

2017年11月，美国心脏病学会（ACC）和美国心脏协会（AHA）发布了预防，检测，评估和治疗成人高血压（BP）的临床实践指南。本文总结了主要建议。

2014年，ACC和AHA任命了一个多学科委员会来更新全国预防，检测，评估和治疗高血压联合委员会的先前报告。该委员会审查了文献并委托进行了非办公室BP监测，降低BP的最佳目标，不同类型的降压药的相对获益和危害以及开始使用BP的相对获益和危害的系统评价和荟萃分析单一降压药或两种药物的组合。

本文总结了以下领域的主要建议：血压分类，血压测量，筛查继发性高血压，非药物治疗，血压阈值和心脏风险评估以指导药物治疗，治疗目标（一般和糖尿病患者，慢性肾脏病患者，和高龄），初始药物治疗的选择，抗药性高血压以及改善高血压控制的策略。